Key result
Spironolactone lowers BP and alleviates target-organ fibrosis in rats with Ang II-induced hypertension.
Why the study?
Does mineralocorticoid receptor blockade mitigate loop diuretic-exacerbated plasma volume contraction and target-organ fibrosis in Angiotensin II-induced hypertension?
Does mineralocorticoid receptor blockade mitigate loop diuretic-exacerbated plasma volume contraction and target-organ fibrosis in Angiotensin II-induced hypertension?
Mineralocorticoid receptor blockade mitigates plasma volume contraction and target-organ fibrosis exacerbated by loop diuretics in a model of Angiotensin II-induced hypertension.
Spironolactone may mitigate furosemide-exacerbated volume contraction and fibrosis in angiotensin II hypertension; hypothesis-generating and requires clinical validation.
Diuretics are widely used antihypertensive agents because of their potent natriuretic effects. However, in hypertension with excessive renin–angiotensin–aldosterone system (RAAS) activation, further volume depletion may aggravate target-organ injury. We investigated the effects of loop diuretics and mineralocorticoid receptor (MR) blockade on plasma volume (PV) and organ injury in angiotensin II (Ang II)-induced hypertension. Male Sprague–Dawley rats were assigned to six groups (n = 6/group) receiving Sham or Ang II with or without furosemide and spironolactone. PV was measured by indocyanine green (ICG) dilution, together with blood pressure, histological, immunohistochemical, and molecular assessments. Longitudinal data were analyzed by two-way repeated-measures ANOVA; animal-level endpoints by one-way ANOVA; histological and immunohistochemical measurements by nested one-way ANOVA; and two-group comparisons by unpaired t tests, with appropriate post hoc testing. Ang II reduced PV, whereas furosemide caused a further decline without additional blood pressure reduction, accompanied by aggravated fibrosis, endothelial impairment, and dysregulation of fibrosis-related proteins. Spironolactone attenuated PV contraction, lowered blood pressure, preserved endothelial integrity, alleviated fibrosis, and partially normalized molecular alterations. MR blockade was associated with attenuation of PV contraction and target-organ injury, supporting a potential relationship between PV homeostasis and organ protection during chronic loop diuretic treatment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Angiotensin II-Induced Hypertension (n=36). Spironolactone and Furosemide vs. Furosemide alone was evaluated on Final systolic blood pressure (SBP) (p=<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: